Michael Tai is CEO of Boston Bioprocess, an innovative CDMO helping biotech companies develop, scale up and optimize fermentation and DSP processes. We work in close partnerships with clients to effectively remove knowledge and capacity bottlenecks in the transition from lab to pilot then to commercial manufacturing.

‍